Crinetics News

Analysts Conflicted on These Healthcare Names: Lexicon Pharmaceuticals (LXRX), Halozyme (HALO) and Crinetics Pharmaceuticals (CRNX)

TipRanksNov 27 00:42 ET · Ratings

LifeSci Capital Maintains Crinetics(CRNX.US) With Buy Rating, Maintains Target Price $82

Moomoo NewsNov 22 15:31 ET · Ratings

Promising Outlook for Crinetics Pharmaceuticals' Paltusotine in Phase 3 Trial Drives Buy Rating

TipRanksNov 22 14:35 ET · Ratings

Crinetics Pharmaceuticals to Participate in Three Upcoming December Investor Conferences

GlobeNewswireNov 15 09:00 ET

Crinetics Pharmaceuticals Third Quarter 2024 Earnings: US$0.96 Loss per Share (Vs US$1.01 Loss in 3Q 2023)

Yahoo FinanceNov 14 07:38 ET

Citi Maintains Crinetics(CRNX.US) With Buy Rating, Raises Target Price to $74

Moomoo NewsNov 14 07:31 ET · Ratings

Crinetics Pharmaceuticals: Promising Future With Innovative Drug Developments and Strong Financial Position

TipRanksNov 14 02:38 ET

Crinetics Pharmaceuticals Analyst Ratings

BenzingaNov 13 13:45 ET · Ratings

JonesTrading Maintains Crinetics(CRNX.US) With Buy Rating, Maintains Target Price $71

Moomoo NewsNov 13 10:31 ET · Ratings

Piper Sandler Maintains Crinetics(CRNX.US) With Buy Rating, Maintains Target Price $97

Moomoo NewsNov 13 08:31 ET · Ratings

Piper Sandler Remains a Buy on Crinetics Pharmaceuticals (CRNX)

TipRanksNov 13 08:19 ET · Ratings

Morgan Stanley Maintains Crinetics(CRNX.US) With Buy Rating, Maintains Target Price $70

Moomoo NewsNov 13 06:36 ET · Ratings

H.C. Wainwright Maintains Crinetics(CRNX.US) With Buy Rating, Raises Target Price to $81

Moomoo NewsNov 13 06:36 ET · Ratings

Crinetics Price Target Raised to $81 From $69 at H.C. Wainwright

TipRanksNov 13 06:26 ET

Crinetics Pharmaceuticals, Inc. (CRNX) Q3 2024 Earnings Call Transcript Summary

moomoo AINov 12 23:13 ET · Conference Call

Crinetics Pharmaceuticals, Inc. (CRNX) Q3 2024 Earnings Call Transcript

Earnings Call TranscriptsNov 12 23:00 ET

LifeSci Capital Maintains Crinetics(CRNX.US) With Buy Rating, Raises Target Price to $82

Moomoo NewsNov 12 21:31 ET · Ratings

Crinetics Pharmaceuticals: Advancing Cancer Treatment With Novel NDC Platform – A Buy Recommendation

TipRanksNov 12 20:47 ET · Ratings

Express News | Crinetics Expects That Its Cash & Equivalents To Be Sufficient To Fund Its Current Operating Plan Into 2029

BenzingaNov 12 16:40 ET

Crinetics | 10-Q: Q3 2024 Earnings Report

SECNov 12 16:21 ET · Announcements